Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

Shorter hormone therapy for prostate cancer

Dr André-Guy Martin speaks to ecancer at EMUC 2019 in Vienna about an improved regimen of hormone therapy.

He outlines a recent study which showed little difference in overall survival if you used a long term hormone therapy regimen.

Dr Martin suggests a shorter regimen for those patients who do not tolerate the therapy particularly well.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

Видео Shorter hormone therapy for prostate cancer канала ecancer
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
24 февраля 2020 г. 20:26:37
00:04:27
ecancer
Правообладателям
Жалоба
Комментарии
Другие видео канала
Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metas...Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metas...Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLCAmivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLCAn AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validat...An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validat...Identifying causing mechanisms in cancers with unknown primary site improves treatment & survivalIdentifying causing mechanisms in cancers with unknown primary site improves treatment & survivalRegional lymph node irradiation in early breast cancerRegional lymph node irradiation in early breast cancerDr. Aizik Wolf -- Cuantas metástasis tratarDr. Aizik Wolf -- Cuantas metástasis tratarHalving duration of ADT for high risk prostate cancer patientsHalving duration of ADT for high risk prostate cancer patientsLatest advances in mHSPC from ASCO GU 2020Latest advances in mHSPC from ASCO GU 2020ESMO 2017: Prostate cancer highlightsESMO 2017: Prostate cancer highlightsTargeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humansTargeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humansNeoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanomaNeoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanomaBreast cancer highlights from ASCO 2019Breast cancer highlights from ASCO 2019Causes, symptoms, and prevention of skin cancerCauses, symptoms, and prevention of skin cancerThe CAR T cell revolution in cancer therapyThe CAR T cell revolution in cancer therapyPhase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patientsPhase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patientsUso de la rapamicina y su implicación en el sistema de "MTor Pathway"Uso de la rapamicina y su implicación en el sistema de "MTor Pathway"CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLLCLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLLCLL14: Venetoclax plus obinutuzumab in untreated CLLCLL14: Venetoclax plus obinutuzumab in untreated CLLProstate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from...Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from...Managing the side effects of CAR T-cell therapyManaging the side effects of CAR T-cell therapyLUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RTLUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RT
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала